Our story

What we do

The minds

Featured works

Talk to us

About

 About us

One client recently explained in a survey that Gardella Alciati “has amazing expertise and procedural understanding . . [b]ut where they truly shine and differentiate themselves from other firms is in their strategic approach. . . . I feel they are playing chess while others are playing checkers.”

Gardella Alciati represents clients from start-ups to multinational corporations in a customized, personal manner that differs from those of larger IP firms. Our professionals bring a variety of perspectives to each matter due to our uniquely broad experience in IP enforcement and patent procurement.

The Gardella Alciati team has directed multinational enforcement campaigns, procured large international patent portfolios, defended and defeated patents in post-grant proceedings, licensed IP portfolios, developed and implemented defensive and risk mitigation strategies for large corporations, and executed trade secret protection programs.

National Awards and Recognition

Our firm and lawyers have been recognized by the following peer-reviewed lawyer ratings organizations

Testimonials

What Our Clients Say

I refer my hardest cases to Greg Gardella of Gardella Grace [now Gardella Alciati] for a good reason. He's hard-working and brilliant.

Peer Review Ranking, Quoting Client

“Cook Alciati works effectively with clients who have had their patents infringed through helping manage expectations and fighting diligently for the best possible monetization outcomes.”

Peer Review Ranking, Quoting Client

"His intellect and working knowledge are phenomenal and it is a pleasure working with him." "He is a huge benefit to anyone who has him in their corner. His deep knowledge of post-grant USPTO trials is second to none."

Peer Review Ranking, Quoting Client

"He is able to synthesize legal solutions for his clients from all angles - anyone who knows Greg knows he is wicked smart."

Peer Review Ranking, Quoting Client

"Greg H. Gardella has taken the lead on many of the higher-profile inter partes reviews. A former Irell, Fish and Oblon lawyer, he 'has real pedigree and an incredible depth of knowledge."

Peer Review Ranking, Quoting Client

"Informed by well-rounded litigation, post-grant and prosecution expertise, Greg Gardella's strategic advice is like gold dust. Hailed for his intellectual processing power, he can unravel a complex patent problem and solve it in the blink of an eye."

Peer Review Ranking, Quoting Client

"The 'phenomenal' Greg H. Gardella is 'extremely experienced in the post-grant space and a dynamic all-round patent consultant."

Peer Review Ranking, Quoting Client

Gardella Grace [now Gardella Alciati] has amazing expertise and procedural understanding of patent challenges—both in Article III courts and in the USPTO. But where they truly shine and differentiate themselves from other firms is in their strategic approach. Greg Gardella, in particular, is a fantastic patent strategist and approaches patent challenges holistically. I feel they are playing chess while others are playing checkers.

Peer Review Ranking, Quoting Client

Our Cases

Representative Cases

ThroughPuter, Inc. v. Microsoft Corporation, 22-cv-00344 (W.D.Was.)
Throughputer, Inc. v. Microsoft Corporation, HP-2022-00009 (United Kingdom)

Gardella Alciati recently settled on behalf its client ThroughPuter, Inc. an international patent dispute with Microsoft. We pursued multiple infringement actions against Microsoft Corporation, one in the Western District of Washington and the other in the United Kingdom. In the Washington case, Gardella Alciati defeated Microsoft’s inter partes review petitions targeting nine out of the eleven patents and the case was heading towards trial. The United Kingdom case was also progressing and was set for trial earlier, in March 2025. Approximately one month before trial was set to begin in the United Kingdom, Microsoft agreed to take a license to the ThroughPuter patents on favorable terms. This was a fantastic result for our client ThroughPuter.

Steuben Food, Inc. v. Shibuya Hoppmann Corp. et al.

Led by Principal Cook Alciati, we obtained a verdict of more than $38 million (plus an amount of prejudgment interest to be determined) in favor of its client Steuben Foods, Inc. following a week-long jury trial before Chief Judge Colm F. Connolly in the United States District Court for the District of Delaware. The jury found all six asserted claims infringed and not invalid and awarded the full amount of damages requested. The verdict came after 10 years of litigation where Greg Gardella worked with Mr. Alciati to defend the validity of the patents-in-suit through both reexamination and inter partes review—more than twenty PTO proceedings in total. On appeal, the Federal Circuit affirmed the jury’s infringement verdict as to the most valuable claims. Mr. Alciati handled all briefing and argument at the Federal Circuit.

The verdict form can be found here.

Hitli Aktiengesellschaft v. Specified Technologies, Inc.

Led by Principal Cook Alciati, we acted as lead counsel for Hilti AG in a dispute with its most fierce direct competitor. Hilti asserted fourteen patents across three cases. Hilti’s competitor asserted two patents against Hilti. Gardella Alciati successfully obtained institution of inter partes review of the two patents asserted against Hilti, winning a stay of the district court case against Hilti. The overall dispute settled shortly thereafter. Following the suit, Hilti’s direct competitor pulled two of the accused devices from the market, essentially providing Hilti with an injunction.

St. Croix Surgical Systems v. Cardinal Health, Inc.

After we refined and sharpened a portfolio of patents directed to novel medical devices, our team, led by Principal Cook Alciati, successfully enforced the new patents against two major industry players resulting in seven figure settlements for our client.  One case settled in the midst of Markman briefing, the other settled following a Markman order that turned in St. Croix’s favor on every disputed construction.  Principal Greg Gardella led the prosecution effort after taking over the portfolio just a few years before patent expiration.

The complaint can be found here.

Fulfillium, Inc. v. ReShape Medical, Inc. et al.

Here again, we refined and sharpened a portfolio of patents directed to novel medical devices. Then our team, led by Principal Cook Alciati, successfully enforced the new patents and related trade secrets in the United States District Court for the Central District of California.  The last defendant settled day before trial resulting in a seven figure settlement that equated to a 60 percent royalty on sales of the accused product.  Principal Greg Gardella led the prosecution effort after taking over the portfolio just a few years before patent expiration and led the effort at the Patent Trial and Appeal Board to defeat multiple petitions for inter partes review, which were denied before institution.

The inter partes review brief (Patent Owner Preliminary Response) can be found here.

A representative complaint can be found here.

Roche Molecular Systems/Ariosa Diagnostics, Inc. v. Sequenom, Inc.

Our professionals represented Ariosa Diagnostics (which was acquired by Roche Molecular Systems) in a bet-the-company case regarding technology involving the use of massively parallel sequencing for the detection of nucleic acid of fetal origin in maternal serum or plasma. We prevailed in multiple inter partes review proceedings.

Petitions can be found here and here.
The related reexamination request can be found here.

Saint Jude Medical v. Medtronic

In this case, patentability challenges sought to establish Saint Jude Medical’s freedom to operate in the renal denervation market, which was projected to grow quickly to more than $3 billion annually. Our team served as lead counsel for requester Saint Jude Medical in nine inter partes reexaminations, and every challenged claim was finally adjudicated to be invalid on multiple grounds.

A representative reexamination request can be found here.

10X Genomics, Inc. v. Bio-Rad Laboratories

We filed twelve inter partes review petitions on behalf of biotechnology company 10X Genomics, Inc. against five patents asserted by Bio-Rad in parallel ITC and district court cases. Our team also filed three reexamination requests against patents asserted by Bio-Rad. In a victory for 10X Genomics, all reexamination requests were granted as to every ground and every claim.

A representative request for reexamination can be found here.


A representative petition can be found here.

Steuben Foods, Inc. v. Nestle USA

Our professionals represented patent owner and aseptic food and beverage manufacturer Steuben Foods in cases involving aseptic bottling technology used by Nestle USA to package more than 2 billion bottles per year. Our team defended ten inter partes review proceedings filed against five patents and prevailed at the Patent Trial and Appeal Board in eight out of the ten cases.

A representative brief can be found here.

TiVo v. DishNetworks

This case involved TiVo’s seminal “time warp” patent on DVR technology. Our team assumed responsibility for the matter after the patent had been finally rejected in a reexamination. Our professionals introduced new evidence and obtained complete reversal of the final rejection. After the patent was affirmed, TiVo collected more than $1 billion in licensing revenue from DishNetworks, Verizon, Microsoft, Cisco and others.

A response (brief) can be found here.

Oracle Corp. v. Clouding IP

Our team served as lead counsel for computer software company Oracle Corp. in more than a dozen inter partes review proceedings in which all petitions were granted. We also negotiated an immediate and very favorite settlement for the company.

A representative petition can be found here.

Main Office

Washington, DC Office

80 M Street SE, 1st Floor
Washington, DC 20003
Phone: 703-556-9600
Fax: 703-740-4541

Chicago Office

2502 North Clark Street, Suite
222 Chicago, IL 60614
Phone: 773-755-4933